NOT-NS-18-072: Notice of New Budget Limitation for PAR-18-657 Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional).

Notice of New Budget Limitation for PAR-18-657 Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional).

Notice Number: NOT-NS-18-072

Key Dates
Release Date: June 14, 2018

Related Announcements
NOT-NS-20-085
PAR-18-657

Issued by
National Eye Institute (NEI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to amend the award budget for PAR-18-657 "Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)."

Section II. Award Information

Currently Reads:

Award Budget

Application budgets may not exceed $2.5 million in direct costs per year.

Many applications will not need to request the maximum budget and the size and duration of the awards will vary because the nature and scope of research programs will vary.

Modified to Read:

Award Budget

Application budgets may not exceed $2.0 million in direct costs per year.

Many applications will not need to request the maximum budget and the size and duration of the awards will vary because the nature and scope of research programs will vary.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

David A. Jett, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-6035
Email: [email protected]